Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 27, 2020
Dec. 28, 2019
Current assets:    
Cash and cash equivalents $ 36,965 $ 22,123
Restricted cash 37 39
Accounts receivable, net of allowance for doubtful accounts of $1,101 and $1,131 73,018 66,677
Inventories, net 84,950 85,195
Income taxes receivable 2,852 3,196
Other current assets 17,296 15,359
Total current assets 215,118 192,589
Property, plant and equipment, net 140,605 145,854
Deferred income taxes 8,837 5,803
Goodwill 346,071 377,569
Other intangible assets, net 286,522 294,651
Other assets 4,627 5,285
Total assets 1,001,780 1,021,751
Current liabilities:    
Accounts payable 29,424 29,730
Accrued compensation and benefits 16,457 16,898
Other accrued expenses and current liabilities 12,159 13,549
Current portion of contingent consideration 797 828
Current portion of long-term non-revolving debt, net 10,216 7,623
Dividends payable 2,888 2,884
Income taxes payable 9,972 4,941
Total current liabilities 81,913 76,453
Revolving lines of credit 193,948 208,708
Long-term non-revolving debt, net 83,267 84,062
Deferred income taxes 48,084 49,290
Other noncurrent liabilities 27,804 25,602
Total liabilities 435,016 444,115
Commitments and contingencies
Shareholders' equity:    
Preferred stock, par value $0.001, 2,000 shares authorized, no shares issued or outstanding
Common stock, par value $0.001, 100,000 shares authorized, 32,081 and 32,047 shares issued and outstanding 32 32
Capital in excess of par value 367,841 365,310
Retained earnings 257,568 267,658
Accumulated other comprehensive loss (58,677) (55,364)
Total shareholders' equity 566,764 577,636
Total liabilities and shareholders' equity $ 1,001,780 $ 1,021,751